Journal profile · RESPIRATORY SYSTEM
Monaldi Archives for Chest Disease
ISSN 1122-0643 · eISSN 2532-5264 · PAGEPress Publications · Italy
Monaldi Archives for Chest Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.8 (journal website); diamond open access (no APC); no APC; median 162 days to acceptance (81 articles, last 24 months); 155 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Monaldi Archives for Chest Disease is published by PAGEPress Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms and Asthma and respiratory diseases, together about 25.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Focus, Scope and Objectives Monaldi Archives for Chest Disease is an international scientific Open Access journal of the Istituti Clinici Scientifici Maugeri, Pavia, Italy, dedicated to the advancement of knowledge in all fields of cardiopulmonary medicine and rehabilitation. Monaldi Archives for Chest Disease publishes original articles, new methodological approaches, reviews, opinions, editorials, position papers on all aspects of cardiac and pulmonary medicine and rehabilitation, and, in addition, provides a forum for the inter-exchange of information, experiences and views on all issues of the cardiology profession, including education. Accordingly, original contributions on nursing, exercise treatment, health psychology, occupational medicine, care of the elderly, health economics and other fields related to the treatment, management, rehabilitation and prevention of cardiac and respiratory disease are welcome. Monaldi Archives for Chest Disease promotes excellence in the profession of cardiology and pneumology through its commitment to the publication of research, support to continuous education, and encouragement and dissemination of best practice. This journal does not apply a charge for publication to Authors as it is supported by institutional funds. Peer review process Introduction Peer review is applied to all research articles and the majority of other article types published in Monaldi Archives for Chest Disease. This entails at least two independent, expert peer reviewers. Letters to the Editor may be subject to peer review at the Editor's discretion. Policy All submissions to Monaldi Archives for Chest Disease are first checked for completeness (criteria for desk reject are available in the Guide for Authors) before being sent to an Editor, who decides whether they are suitable for peer review. If an Editor is on the author list or has a competing interest in a particular manuscript, another member of the Editorial Board will be assigned to oversee peer review. When making a decision, Editors will consider the peer-reviewed reports, but they will not be bound by the opinions or recommendations contained in them. A single peer reviewer's or the Editor's concern may result in the manuscript being rejected. Peer review reports are sent to authors along with the editorial decision on their manuscript. At Monaldi Archives for Chest Disease papers undergo a single-blind review process - meaning that the reviewers’ identity is not shared with the
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief A. SpanevelloPublisher website
Editorial board by country: none in mainland China; most named Italy 46, Canada 1, Australia 1, Brazil 1, Portugal 1 (51 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine11.2%
- Respiratory Support and MechanismsMedicine8%
- Asthma and respiratory diseasesMedicine6.4%
- Tracheal and airway disordersMedicine5.9%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.8%
- COVID-19 Clinical Research StudiesMedicine5.4%
- Cardiac Health and Mental HealthMedicine5.2%
- Tuberculosis Research and EpidemiologyMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePubMedPublisher website
Other: Scilit, SCImago, OpenAlex
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.8Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- CiteScore (publisher)
- 1.8Publisher website ·
- SJR 2026-06
- 0.27LetPub ·
- SNIP 2026-06
- 0.41LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 317OpenAlex ·
- 2-year mean citedness
- 0.71OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.34%LetPub ·
Volume
- Articles per year
- 110LetPub ·
Articles by year OpenAlex count · 1,896 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 86 | 86 | 4 |
| 2025 | 155 | 155 | 89 |
| 2024 | 120 | 120 | 162 |
| 2023 | 124 | 124 | 261 |
| 2022 | 127 | 127 | 471 |
| 2021 | 189 | 189 | 1,027 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
162 daysMedian, submission to acceptance · P25–P75 113 days – 228 days
- Acceptance to online
- median 42 days (81 articles)
- Submission to online
- median 220 days
- Sample
- 81 articles with submission and acceptance dates (377 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted9, with length limits
- case reportgnate the major divisions of the paper. Case Reports (about 2000 words, abstract 150 words max, 20 references max, 3 tables and/ormain text ≤ 2,000 words
- case reportsCase Reports (about 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures): Reports describing observations on clinical cases that can …Length not stated
- letters to the editorAll manuscripts must contain the following sections: Ethics approval and consent to participate - Consent for publication - Availability of data and material - …main text ≤ 1,000 words · references ≤ 3
- original articleto make a submission. Author Guidelines Original Articles (3500 words max, abstract 350 words max, 50 references max, 3/5 tablesmain text ≤ 3,500 words
- original articlesOriginal Articles (3500 words max, abstract 350 words max, 50 references max, 3/5 tables and/or figures): Reports of basic and applied research in the field of …Length not stated
- perspectiveDiscussion, Conclusions and References. Perspectives / Letters to the Editor (1000 words max, abstract optional, 3 references): Letters should addremain text ≤ 1,000 words
- perspectives / letters to the editorPerspectives / Letters to the Editor (1000 words max, abstract optional, 3 references): Letters should address specific scientific issues raised by papers publi…Length not stated
- reviewshould be listed in an ad hoc Appendix. Reviews (5000 words max, abstract 250 words max, 40 to 100 references, 3/5 tablmain text ≤ 5,000 words
- reviewsReviews (5000 words max, abstract 250 words max, 40 to 100 references, 3/5 tables and/or figures): They should be introduced by a general summary of content in …Length not stated
Policy excerpts from the journal's websitePublication ethics, License & copyright, Open access, Peer review
- Publication ethics Misconduct
False or misleading information, such as identity theft and suggesting fake peer-reviewers, will result in the manuscript being rejected, further investigation in accordance with the Publisher’s misconduct policy (https://www.pagepress.org/site/plagiarism_misconduct), and notification to the authors' institutions/employers. The Publisher follows the Committee on Publication Ethics (COPE) guidance …
Source ↗Publisher website ·- License & copyright Copyright Notice
Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) applies to all manuscripts. Model summary
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.An Open Access Publication is one that meets the following two conditions: the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit a…
Source ↗Publisher website ·- Open access Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·- Peer review Peer review process
Single-blind peer review. Model summary
Introduction Peer review is applied to all research articles and the majority of other article types published in Monaldi Archives for Chest Disease. This entails at least two independent, expert peer reviewers. Letters to the Editor may be subject to peer review at the Editor's discretion. Policy All submissions to Monaldi Archives for Chest Disease are first checked for completeness (criteria fo…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- PAGEPress Publications
- Country or region
- Italy
- Language
- English
- ISSN
- 1122-0643
- Electronic ISSN
- 2532-5264
- Latest issue on the website
- Volume 96, Issue 3 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Monaldi Archives for Chest Disease
What CAS zone is Monaldi Archives for Chest Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Monaldi Archives for Chest Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Monaldi Archives for Chest Disease?
The journal's website gives an impact factor of 0.8; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.8, h-index 43.
How long does peer review take at Monaldi Archives for Chest Disease?
Based on the dates recorded on 81 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 162 days (interquartile range 113–228 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Monaldi Archives for Chest Disease based?
Of the 51 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (46), Canada (1) and Australia (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Monaldi Archives for Chest Disease?
According to LetPub and DOAJ records, Monaldi Archives for Chest Disease is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PubMed; that list has not been checked against each database.
Is Monaldi Archives for Chest Disease open access, and what is the APC?
Monaldi Archives for Chest Disease is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .